Re:BPOM (Indonesian FDA) Approves Ivermectin as Covid-19 The...
by tboyd47 on Thursday July 15, 2021 @10:54AM
(#27845475)
A vaccine can't have a sample size. A study can have a sample size, but I'm not aware of any that have administered hundreds of millions of doses. If you're referring to the general rollout of the vaccine, then that is not a randomized, controlled trial.
And IIRC, the "wonderful chart" you're referring to (I assume you mean PCR positive tests or "cases") can not be credited to the vaccine rollout. It peaked when only 8 million doses had been given, and the age distribution of the decline in cases did not match the vaccine recipients' age distribution [0].
---
[0] https://www.msn.com/en-us/news/us/covid-19-cases-plunging-to...
Re:BPOM (Indonesian FDA) Approves Ivermectin as Covid-19 The...
by yehosef on Thursday July 15, 2021 @10:25AM
(#27845109)
Exactly, why solve the problem with a cheap, tried-and-tested anti-viral when we can use expensive and experimental novel vaccines with no long term-term safety studies?
Re:BPOM (Indonesian FDA) Approves Ivermectin as Covid-19 The...
by incrudible on Thursday July 15, 2021 @11:09AM
(#27845656)
This is a false dichotomy. Ivermectin doesn't solve the problem. Ivermectin is in widespread use, it didn't solve the problem anywhere. Maybe it's 50% effective, which would be a great result for a drug - it still wouldn't solve the problem.
For me, as a US citizen, my energy is far better spent getting people to take the vaccine that has a sample size of hundreds of millions of doses and has given us a wonderful chart that's going down and to the left. And, to put it bluntly, podcasts guests trying to make a name for themselves for pushing alternatives as "contrarians" have no place in this discourse.